Journal of Medicinal Chemistry · 2015 · 110 citations · 25 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoverySynthetic Medicinal ChemistryAmyloid FormationLigand BindingLigand-based DesignAlpha-synuclein AggregationAlpha-synuclein MisfoldingAmyloid Beta PeptidesAmyloid FibrilsAmyloid StructureDouble Bond ConfigurationSelectivity
A series of 3-(benzylidine)indolin-2-one derivatives were synthesized and evaluated for their in vitro binding to alpha synuclein (α-syn), beta amyloid (Aβ), and tau fibrils. Compounds with a single double bond in the 3-position had only a modest affinity for α-syn and no selectivity for α-syn versus Aβ or tau fibrils. Homologation to the corresponding diene analogues yielded a mixture of Z,E and E,E isomers; substitution of the indoline nitrogen with an N-benzyl group resulted in increased binding to α-syn and reasonable selectivity for α-syn versus Aβ and tau. Introduction of a para-nitro group into the benzene ring of the diene enabled separation of the Z,E and E,E isomers and led to the identification of the Z,E configuration as the more active regioisomer. The data described here provide key structural information in the design of probes which bind preferentially to α-syn versus Aβ or tau fibrils.
25
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
William E. Klunk, Henry Engler, Agneta Nordberg et al. · Annals of Neurology · 2004 · 4.5K citations
Medicine, Neurology, Neuroscience +15
Use of Florbetapir-PET for Imaging β-Amyloid Pathology
Christopher M. Clark · JAMA · 2011 · 1.1K citations · Full text
Medicine, Neurology, Neuroscience +14